|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement显示文摘 | Mark P. Callery MD Kenneth J. Chang MD Elliot K. Fishman MD Mark S. Talamonti MD L. William Traverso MD David C. Linehan MD | 2009 | Annals of Surgical Oncology2009，，7： | 3 |
| 2 | Intraductal papillary mucinous neoplasm and the pancreatic incidentaloma显示文摘Asymptomatic pancreatic lesions(APL) are a commonly encountered problem in today's pancreatic surgical practices.Current literature regarding etiologies and incidence of APLs,particularly intraductal papillary mucinous neoplasm(IPMN),is presented.APLs constitute a wide spectrum of pathology(solid/cystic,benign/premalignant/malignant) but,overall,IPMN is now the most common diagnosis.The Sendai Guidelines and their function as a basis for risk stratification in branch duct IPMN are presented.The importance of traditionally analyzed cyst characteristics including size,presence of mucin or nodules and cyst fluid aspirate as indicators of malignancy is emphasized,noting also the potential correlation of main duct dilatation,thickened septae and elevated cyst fluid CEA with increased risk of malignancy.Current complication rates after resection of APLs are reviewed and found to be generally equivalent to those for symptomatic resections.A potential multidisciplinary treatment strategy is offered considering the costs of surgery versus repeated imaging or follow up endoscopy for these lesions.The decision for intervention is ultimately based on the Sendai Guidelines in the context of the individual patient. | Tara S Kent Charles M Vollmer Jr Mark P Callery | 2010 | World Journal of Gastrointestinal Surgery2010，2，10： | 3 |
| 3 | Deviation-Based Cost Modeling: A Novel Model to Evaluate the Clinical and Economic Impact of Clinical Pathways显示文摘 | Tsafrir Vanounou Wande Pratt Josef E. Fischer Charles M. Vollmer Mark P. Callery | 2007 | Journal of the American College of Surgeons2007，，4： | 2 |
| 4 | Risk Prediction for Development of Pancreatic Fistula Using the ISGPF Classification Scheme显示文摘 | Wande B. Pratt Mark P. Callery Charles M. Vollmer | 2008 | World Journal of Surgery2008，，3： | 2 |
| 5 | Prevention and Management of Pancreatic Fistula显示文摘 | Mark P. Callery Wande B. Pratt Charles M. Vollmer | 2009 | Journal of Gastrointestinal Surgery2009，，1： | 2 |
| 6 | Prevention and Management of Pancreatic Fistula显示文摘 | Mark P. Callery Wande B. Pratt Charles M. Vollmer | 2009 | Journal of Gastrointestinal Surgery2009，，1： | 2 |
| 7 | The Incidental Asymptomatic Pancreatic Lesion: Nuisance or Threat?显示文摘 | Teviah Sachs Wande B. Pratt Mark P. Callery Charles M. Vollmer | 2009 | Journal of Gastrointestinal Surgery2009，，3： | 2 |
| 8 | Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement显示文摘 | Mark P. Callery MD Kenneth J. Chang MD Elliot K. Fishman MD Mark S. Talamonti MD L. William Traverso MD David C. Linehan MD | 2009 | Annals of Surgical Oncology2009，，7： | 2 |
| 9 | Risk Prediction for Development of Pancreatic Fistula Using the ISGPF Classification Scheme显示文摘 | Wande B. Pratt Mark P. Callery Charles M. Vollmer | 2008 | World Journal of Surgery2008，，3： | 2 |
| 10 | Clinical and Economic Validation of the International Study Group of Pancreatic Fistula (ISGPF) Classification Scheme显示文摘 | Wande B. Pratt Shishir K. Maithel Tsafrir Vanounou Zhen S. Huang Mark P. Callery Charles M. Vollmer | 2007 | Annals of Surgery2007，，3： | 2 |
| 11 | Postoperative pancreatic fistulas are not equivalent after proximal, distal, and central pancreatectomy显示文摘 | Wande Pratt B.A. Shishir K. Maithel M.D. Tsafrir Vanounou M.D. Mark P. Callery M.D. Charles M. Vollmer M.D | 2006 | Journal of Gastrointestinal Surgery2006，，9： | 2 |
| 12 | Risk of bacteremia from temperary hemodialysis catheters by site of insertion and elutriatlon of use: a prospective stady显示文摘 | Olivermj Callery Sm Thorprke | 2000 | Kidney Int2000，58，6： | 1 |
| 13 | Pretreatment assess- ment of resectable and borderline resectable pancreatic cancer: expert consensus statement 显示文摘 | Callery MP Chang KJ Fishman EK | 2009 | Ann Surg Oncol2009，16，7： | 1 |
| 14 | Pretreatment assessment of resectable and borderline resectable pancreatic cancer : expert consensus statement 显示文摘 | Callery MP Chang KJ Fishman EK | 2009 | Ann Surg Oncol2009，16，7： | 1 |
| 15 | Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use:A prospective study显示文摘 | Oliver M Callery S Thorpe K | 2000 | Kidney Int2000，58，： | 1 |
| 16 | Circulating endothelial cells as a novel marker of angiogenesis 显示文摘 | Mancuso P Calleri A Cassi C | 2003 | Adv Exp Med Biol2003，522，： | 1 |
| 17 | Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy显示文摘 | Mark P Callery Steven M Strasberg Gerard M Doherty Nathaniel J Soper Jeffrey A Norton | 1997 | Journal of the American College of Surgeons1997，，1： | 1 |
| 18 | Caring for parents of hospitalized children:A hidden area of nursing work显示文摘 | Callery P | 1997 | J Adv Nurs1997，26，5： | 1 |
| 19 | Chromatographic methods of analysis of antibiotics in milk显示文摘 | Schenck F J Callery P S | | 0，，： | 1 |
| 20 | The bridge stent tech- nique for salvage of pancreaticojejunal anastomotic dehis- cence 显示文摘 | Kent TS Callery MP Vollmer CM Jr | 2010 | HPB (Oxford)2010，12，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员